Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV ...

In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

With proper data governance, the pharma industry can improve patient-centricity in trials and bring lifesaving therapies to ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Mallinckrodt and Endo are merging in a cash and stock deal worth some $6.7 billion, the companies said Thursday. Under the ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare.

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

In the week when U.S. President Donald Trump sounded alarm bells about Ireland “stealing the U.S. pharmaceutical industry” ...